Lombard Odier Asset Management (Switzerland)’s Kura Oncology KURA Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-113,674	Closed	-$1.39M	–	274
2023 Q1	$1.39M	Sell	113,674 -66,826	-37%	-$834K	0.12%	156
2022 Q4	$2.24M	Sell	180,500 -37,866	-17%	-$550K	0.18%	113
2022 Q3	$2.98M	Sell	218,366 -15,907	-7%	-$245K	0.25%	93
2022 Q2	$4.29M	Sell	234,273 -99	-0%	-$1.42K	0.36%	69
2022 Q1	$3.77M	Buy	234,372 +15,875	+7%	+$229K	0.3%	69
2021 Q4	$3.06M	Buy	218,497 +18,482	+9%	+$299K	0.2%	78
2021 Q3	$3.75M	Buy	200,015 +58,669	+42%	+$1.11M	0.23%	84
2021 Q2	$2.95M	Buy	141,346 +37,053	+36%	+$920K	0.15%	98
2021 Q1	$2.95M	Buy	+104,293	New	+$3.3M	0.2%	88

Other funds holding KURA

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s KURA Position: Q2 2023 in Review

Lombard Odier Asset Management (Switzerland) sold out of Kura Oncology (KURA) in Q2 2023, closing a stake of 113,674 shares — an estimated $1.39M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in KURA in Q1 2021 and held it in 9 quarters. The position peaked at $4.29M in Q2 2022. 148 funds tracked by Wall St. Rank hold KURA as of Q2 2023.

Lombard Odier Asset Management (Switzerland) reported no remaining Kura Oncology position as of Q2 2023 after selling out during the quarter.
Lombard Odier Asset Management (Switzerland) sold 113,674 Kura Oncology shares in Q2 2023, an estimated $1.39M.
Lombard Odier Asset Management (Switzerland) first reported a position in Kura Oncology in Q1 2021 and held it in 9 quarters.
Lombard Odier Asset Management (Switzerland)'s Kura Oncology position peaked at $4.29M in Q2 2022.
148 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2023.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 14 Aug 2023.